Vaccine Adjuvants Market

This study involved four major activities in estimating the current size of the vaccine adjuvants market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the vaccine adjuvants market. The secondary sources used for this study include National Institute of Cancer (NIC), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), National Institute of Allergy and Infectious Diseases (NIAID), United States Department of Health and Human Services, United States Agency for International Development, International Society for Vaccines, UNICEF, GAVI, PAHO, Medical Research Council. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global vaccine adjuvants market, which was validated through primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the vaccine adjuvants market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

• The major players in the industry and market have been identified through extensive primary and secondary research.
• The revenues generated from the vaccine adjuvants business of players operating in the market have been determined through secondary research and primary analysis.
• All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Global Vaccine Adjuvants Market Size: Bottom-Up Approach

To know about the assumptions considered for the study, Request for Free Sample Report

Global Vaccine Adjuvants Market Size: Top-down Approach

Data Triangulation

After estimating the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

An adjuvant is a substance that is included in a vaccine formulation to enhance the immune-stimulating properties of a vaccine to the antigen. There are various functions of an adjuvant, such as increasing immunogenicity, enhancing the magnitude, breadth and durability of the immune response, and improving the efficacy of a vaccine. Adjuvants are used in different types of human and veterinary vaccines to prevent various diseases

Key Stakeholders

• Vaccine adjuvant manufacturers
• Vaccine manufacturers
• Vaccine adjuvant associations
• Vaccine adjuvant research institutes
• Vaccine product distributors
• Vaccine adjuvant raw material suppliers
• Vaccine adjuvant development institutes and organizations
• Biotechnology & biopharmaceutical companies
• Drug manufacturers, vendors, and distributors
• Academic & government research institutes
• Venture capitalists & investors
• Government organizations
• Private research firms
• Research & development (R&D) companies

Report Objectives

• To define, describe, and forecast the vaccine adjuvants market by product, route of administration, disease type, application, type, and region
• To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
• To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall vaccine adjuvants market
• To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East & Africa (MEA)
• To profile the key players and analyze their market shares and core competencies
• To track and analyze competitive developments, such as product launches, acquisitions partnerships, agreements, collaborations, and expansions
• To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country-wise Information:

• Analysis for additional countries (up to five)

Company Information:

• Detailed analysis and profiling of additional market players (up to five)